EXT2

Chr 11ADAR

exostosin glycosyltransferase 2

Also known as: SOTV, SSMS

This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.773 OMIM phenotypes
Clinical SummaryEXT2
🧬
Gene-Disease Validity (ClinGen)
exostoses, multiple, type 2 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
243 unique Pathogenic / Likely Pathogenic· 407 VUS of 1041 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — EXT2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.77LOEUF
pLI 0.000
Z-score 2.73
OE 0.53 (0.380.77)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.64Z-score
OE missense 0.91 (0.840.99)
394 obs / 431.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.53 (0.380.77)
00.351.4
Missense OE?0.91 (0.840.99)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 21 / 39.5Missense obs/exp: 394 / 431.4Syn Z: -0.24
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveEXT2-related multiple exostosesLOFAD

This gene — mechanism propensity

DN
0.6259th %ile
GOF
0.5366th %ile
LOF
0.3261th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF1 literature citation · 86% of P/LP variants are LoF · ClinGen HI: Sufficient evidence for dosage pathogenicity
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

LOFAnalysis of mutations in EXT1 and EXT2 in Brazilian patients with multiple osteochondromas1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 29529714

ClinVar Variant Classifications

1041 submitted variants in ClinVar

Classification Summary

Pathogenic199
Likely Pathogenic44
VUS407
Likely Benign263
Benign57
Conflicting49
199
Pathogenic
44
Likely Pathogenic
407
VUS
263
Likely Benign
57
Benign
49
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
175
6
18
0
199
Likely Pathogenic
33
9
0
2
44
VUS
6
364
30
7
407
Likely Benign
0
20
93
150
263
Benign
0
6
44
7
57
Conflicting
49
Total2144051851661,019

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 30) ClinVar copy-number / structural variants overlap EXT2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

EXT2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.